|
|
Volumn 2, Issue 8, 2001, Pages 1307-1315
|
|
Peginterferon alpha-2b: A new approach to improving response in hepatitis C patients
a
a
|
|
Author keywords
Hepatitis C; Peginterferon alpha 2b; Pharmacodynamics; Pharmacokinetics; Polyethylene glycol; Therapy
|
|
Indexed keywords
ALPHA2B INTERFERON;
ALPHACON 1;
BETA 2 MICROGLOBULIN;
CYTOKINE;
FC RECEPTOR;
INTERFERON;
MACROGOL;
MAJOR HISTOCOMPATIBILITY ANTIGEN;
MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;
MEMBRANE PROTEIN;
MESSENGER RNA;
PEGINTERFERON ALPHA2B;
RECOMBINANT ALPHA2A INTERFERON;
RECOMBINANT ALPHA2B INTERFERON;
RIBAVIRIN;
UNCLASSIFIED DRUG;
ANTIVIRAL ACTIVITY;
AREA UNDER THE CURVE;
ARTICLE;
CLINICAL TRIAL;
COMORBIDITY;
CONTROLLED CLINICAL TRIAL;
COST EFFECTIVENESS ANALYSIS;
DISEASE COURSE;
DOSE RESPONSE;
DRUG ABSORPTION;
DRUG ACTIVITY;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG CONTRAINDICATION;
DRUG COST;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG FORMULATION;
DRUG HALF LIFE;
DRUG RESPONSE;
DRUG SAFETY;
DRUG TOLERABILITY;
ETHNIC GROUP;
FEVER;
GASTROINTESTINAL DISEASE;
HEADACHE;
HEPATITIS C;
HEPATITIS C VIRUS;
HUMAN;
KIDNEY DISEASE;
LIVER TRANSPLANTATION;
MAINTENANCE THERAPY;
MENTAL DISEASE;
MULTICENTER STUDY;
MUSCULOSKELETAL DISEASE;
PATIENT CARE;
POSTMARKETING SURVEILLANCE;
RANDOMIZED CONTROLLED TRIAL;
RELAPSE;
RIGOR;
SKIN DISEASE;
UNITED STATES;
VIROLOGY;
ANIMALS;
ANTIVIRAL AGENTS;
CLINICAL TRIALS;
HEPATITIS C;
HEPATITIS C, CHRONIC;
HEPATITIS, VIRAL, HUMAN;
HUMANS;
INTERFERON ALFA-2A;
INTERFERON ALFA-2B;
POLYETHYLENE GLYCOLS;
|
|
EID: 0034863358
PISSN: 14656566
EISSN: None
Source Type: Journal
DOI: 10.1517/14656566.2.8.1307 Document Type: Article |
|
Times cited : (16)
|
|
References (15)
|
